New heart mapping technology aims to better target irregular heartbeat sources

NCT ID NCT06960252

Recruiting now Disease control Sponsor: Ting-Yung Chang Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new high-density mapping catheter called OPTRELL can better identify the specific areas in the heart that maintain persistent atrial fibrillation (AF). Researchers will use this mapping to guide radiofrequency ablation procedures in 80 patients with persistent AF that hasn't responded well to medication. The goal is to see if this targeted approach leads to better long-term control of irregular heart rhythms compared to standard treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Taipei Veterans General Hospital
RECRUITING

Taipei, Outside US, 112, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ATRIAL FIBRILLATION (AF)